$Cidara Therapeutics(CDTX)$Wedbush liftsprice target to $6 from $5 on Echinocandin Rezafugin Trial Data; Outperform Rating kept.
$Cidara Therapeutics(CDTX)$Wedbush liftsprice target to $6 from $5 on Echinocandin Rezafugin Trial Data; Outperform Rating kept.
精彩评论